BUZZ-Penumbra rises after FDA clears stroke clot-removal device

Penumbra, Inc.

Penumbra, Inc.

PEN

0.00

** Shares of medical equipment maker Penumbra PEN.N rise 1.98% to $324.62 in extended trading

** Co says it received U.S. FDA clearance for Thunderbolt, a device used to remove clots in patients with acute ischemic stroke, which occurs when blood flow to the brain is blocked

** Says the device is designed to help remove clots faster and more completely, which can help restore blood flow to the brain

** Says Thunderbolt brings its vacuum clot-removal technology to stroke care, making it the only such device available for stroke treatment in the U.S.

** Says the device will be sold with some of PEN's existing stroke-treatment catheters

** "Investors have been waiting for a long time for this approval. It is good to see this come through and allays concerns of any potential issues with the data," says brokerage Evercore ISI

** As of last close, PEN up 2.38% YTD


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.